Astera Labs, INC Form 4 insider transactions

Director Manuel Alba of Astera Labs sold shares of common stock on September 20 and 23, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Sanjay Gajendra, President and COO of Astera Labs, sold shares of the company's common stock on September 17, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Astera Labs' President and COO, Sanjay Gajendra, sold shares of common stock on August 30, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Michael Truett Tate, CFO of Astera Labs, Inc., sold shares of common stock on August 29, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Michael E. Hurlston, a director at Astera Labs, exercised stock options to acquire 40,000 shares of common stock at $0.31 per share on August 27, 2024.

Philip Mazzara, General Counsel and Secretary of Astera Labs, amended a previous Form 4 filing to correct the number of shares sold on August 23 and 26, 2024.

Philip Mazzara, General Counsel and Secretary of Astera Labs, Inc., sold shares of common stock between August 23 and August 26, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Michael Truett Tate, CFO of Astera Labs, sold 13,915 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Philip Mazzara, General Counsel and Secretary of Astera Labs, sold 7,260 shares of common stock on August 16, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Sutter Hill Ventures, a major shareholder of Astera Labs, distributed shares pro rata to its limited partners on August 15, 2024, without additional consideration.

Chief Financial Officer of Astera Labs, Michael Tate, reports the acquisition of restricted stock units and an update to previously reported beneficial ownership.

Philip Mazzara, General Counsel and Secretary of Astera Labs, reports the acquisition of 25,304 shares of common stock through a restricted stock unit (RSU) award.

Director Bethany Mayer acquired 4,573 shares of Astera Labs common stock on June 23, 2024, as part of a restricted stock unit award.

Philip Mazzara, General Counsel and Secretary of Astera Labs, sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Michael Tate, CFO of Astera Labs, sold shares of common stock on May 16, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Sutter Hill Ventures and related individuals report the conversion of preferred stock to common stock in Astera Labs, Inc. following the company's initial public offering.

Director Stefan A. Dyckerhoff reports the conversion of preferred stock to common stock following Astera Labs' initial public offering on March 22, 2024.

Director Jack R. Lazar purchased 10,000 shares of Astera Labs, Inc. at $36 per share through a directed share program related to the company's IPO.

Philip Mazzara, General Counsel and Secretary of Astera Labs, reports the withholding of shares to cover tax obligations related to vested restricted stock units.

Director Michael Hurlston reports the acquisition of 21,747 shares of Astera Labs, Inc. common stock at $36 per share through a directed share program related to the company's IPO.

Director Manuel Alba reports the conversion of preferred stock to common stock and acquisition of shares through a spouse's directed share program following Astera Labs' IPO.

Michael Truett Tate, CFO of Astera Labs, reports the withholding of shares for tax obligations and the conversion of Series A Preferred Stock to Common Stock following the company's IPO.

Jitendra Mohan, CEO of Astera Labs, reports the conversion of Series A Preferred Stock to Common Stock following the company's IPO.

Philip Mazzara, General Counsel and Secretary of Astera Labs, reports the acquisition of 37,500 shares of common stock on January 24, 2024, prior to the company's IPO.

Sanjay Gajendra, President and COO of Astera Labs, reports the acquisition of restricted stock units and beneficial ownership through trusts.

Chief Financial Officer Michael Truett Tate reports the acquisition of common stock and restricted stock units in Astera Labs, Inc.

CEO Jitendra Mohan reports the acquisition of 2,704,335 shares of common stock in Astera Labs through a restricted stock unit (RSU) award, along with details of beneficial ownership held through various trusts.